Laser Artery Disease Therapy: FDA approves next-gen laser atherectomy catheter
Feb. 17, 2016
Spectranetics (Colorado Springs, CO) has received FDA 510(k) clearance for its Turbo-Power laser atherectomy catheter to treat in-stent restenosis (ISR). The company notes that laser atherectomy is driving a new standard of care for treatment of coronary artery disease, with improved clinical outcomes. The tool uses vaporizing technology to maximize luminal gain-it debulks the lesion in a single step and offers remote automatic rotation for precise directional control.

About the Author
Barbara Gefvert | Editor-in-Chief, BioOptics World (2008-2020)
Barbara G. Gefvert has been a science and technology editor and writer since 1987, and served as editor in chief on multiple publications, including Sensors magazine for nearly a decade.
Sponsored Recommendations
Sponsored Recommendations
Working with Optical Density
Feb. 26, 2025
Finding the Right Dichroic Beamsplitter
Feb. 26, 2025
Measurement of Optical Filter Spectra
Feb. 26, 2025
Voice your opinion!
Voice your opinion!